Toggle navigation
Home
Search
Services
Blog
Contact
About
Single Primer Mediated Cloning of P53 Regulated Genes
Passavant, Charles W.
Cascade Oncogenics, Inc., Portland, OR, United States
Search 6 grants from Charles Passavant
Search grants from Cascade Oncogenics, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Tetrabromobisphenol A (TBBPA) as a modulator of tryptophan catabolism and maternal-fetal health
Programmatic: Expanding Innovative Multidisciplinary Medical Education in Zambia
Assessing Social Value in Economic Evaluation to Scale Up Novel TB Drug Regimens
Mass Spectorometry and Proteomics Core
The CLASS Project: Community of Learners Achieving Science Success 2012-2017
Recently added grants:
Generating mtDNA mutant mice to model human mitochondrial diseases
A DNA origami platform for measuring membrane protein interactions
RNA-binding proteins in mosquito development
A model for predicting response to PD-1 inhibitors in NSCLC
Contributions of IRF5 to Chikungunya Viral Arthritis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
9R44CA072451-02
Application #
2010543
Study Section
Special Emphasis Panel (ZRG2-SSS-Y (09))
Project Start
1996-09-30
Project End
1998-09-29
Budget Start
1996-09-30
Budget End
1997-09-29
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Cascade Oncogenics, Inc.
Department
Type
DUNS #
City
Portland
State
OR
Country
United States
Zip Code
97201
Related projects
NIH 1997
R44 CA
Single Primer Mediated Cloning of P53 Regulated Genes
Passavant, Charles W. / Cascade Oncogenics, Inc.
NIH 1996
R44 CA
Single Primer Mediated Cloning of P53 Regulated Genes
Passavant, Charles W. / Cascade Oncogenics, Inc.
Comments
Be the first to comment on Charles Passavant's grant